Eloxatin Related Clinical Trials
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer [Active, not recruiting]
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma [Active, not recruiting]
A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC [Active, not recruiting]
Endometrial Cancer - LOHP Alone and With 5FU [Completed]
Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer [Active, not recruiting]
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer [Active, not recruiting]
Oxaliplatin and Cetuximab in First-Line Treatment of Metastatic Colorectal Cancer (mCRC) [Active, not recruiting]
Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck [Completed]
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin [Completed]
A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma [Completed]
CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer [Terminated]
TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer [Completed]
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) [Completed]
Oxaliplatin and Docetaxel as First-Line Therapy for Advanced Non-Small Cell Lung Cancer [Active, not recruiting]
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer [Recruiting]
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer [Completed]
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer [Active, not recruiting]
Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer [Terminated]
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer [Completed]
Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer [Active, not recruiting]
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery [Active, not recruiting]
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. [Active, not recruiting]
Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer [Completed]
Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer [Completed]
Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer [Completed]
Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients [Recruiting]
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL [Active, not recruiting]
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer [Recruiting]
Oxaliplatin and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Suspended]
Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery [No longer recruiting]
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer [Recruiting]
MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer [No longer recruiting]
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II or Stage III or Recurrent Non-Small Cell Lung Cancer [Recruiting]
Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem [Recruiting]
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
Docetaxel+Oxali+/-Cetux Met Gastric/GEJ [Recruiting]
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer [Recruiting]
Stage IV Colorectal CA ALIMTA [Suspended]
Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater [Recruiting]
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer [Recruiting]
FLOX in Combination With Cetuximab in First-Line Treatment of Colorectal Cancer [Active, not recruiting]
Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients [Recruiting]
Hepatic Artery Infusion With Oxaliplatin [Recruiting]
Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis [Recruiting]
Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas [Recruiting]
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer [Recruiting]
A Phase II Study of Oxaliplatin Capecitabine and Pre-Operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer [No longer recruiting]
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. [Recruiting]
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer [Terminated]
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [No longer recruiting]
Study of Radiation Therapy and Concurrent Capecitabine and Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma [Recruiting]
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma [Recruiting]
Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer [Recruiting]
Safety and Efficacy Study of XELOX Vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer [Completed]
Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer [Recruiting]
Xelox (Xeloda + Oxaliplatin) and Avastin for Metastatic Esophagogastric Adenocarcinoma [Recruiting]
Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity [Recruiting]
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Recruiting]
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer [Recruiting]
Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [No longer recruiting]
Clinical Studies of Gemcitabine-Oxaliplatin [Recruiting]
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]
A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer [Recruiting]
Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias [Recruiting]
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas [No longer recruiting]
Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma [Recruiting]
Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction [Completed]
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum [Recruiting]
Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer [Recruiting]
Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer [Recruiting]
Phase I Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer [Recruiting]
Adjuvant Gemcitabine Plus Oxaliplatin vs. Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC [Recruiting]
Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma [Recruiting]
Docetaxel and Oxaliplatin in Gastric Cancer [Recruiting]
Oxaliplatin and 5-FU Based Preoperative Chemoradiation [Recruiting]
Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma [Recruiting]
Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer [No longer recruiting]
Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases [No longer recruiting]
Etoposide, Oxaliplatin and Capecitabine in Advanced HCC [Recruiting]
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer [Recruiting]
FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer [Recruiting]
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer [Recruiting]
TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary [Recruiting]
Oxaliplatin in Cancer Patients With Impaired Kidney Function [Completed]
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor [Recruiting]
Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer [No longer recruiting]
Safety Study of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-Advanced Rectal Cancer [Recruiting]
Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors [No longer recruiting]
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer [No longer recruiting]
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma [Recruiting]
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma [No longer recruiting]
Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma [Not yet recruiting]
Phase I Study of GemOx and Vandetanib in Advanced Solid Malignancy [Not yet recruiting]
Oxaliplatin in Unresectable Hepatocellular Carcinoma [Completed]
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer [Recruiting]
OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer [No longer recruiting]
Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer [No longer recruiting]
A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer [Recruiting]
|
